
After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
Operation against terror is going on in Jammu and Kashmir. Today is the 12th day of the ongoing e
IPL 2022: Ian Bishop and Daniel Vettori angry with Sanju Samson, saying 'wasting...'
It is pleasant to watch Rajasthan Royals captain Sanju Samson bat, but it can also be disappointi
No mobile, no TV for two hours in Maharashtra village: Kids go inside as soon as the siren sounds
When we had just reached the village, a siren started blaring. Children playing on the roads were
After the weakening of the second wave of coronavirus infection, now the third wave is being fear
Champions Trophy 2025: Chaos erupts over not hoisting Indian flag in Pakistan stadium, fans angry
A controversy has surfaced even before the start of the ICC Champions Trophy 2025. In the video g
Lakhimpur Kheri Violence: Ashish Mishra, son of Union Minister of State for Home and BJP leader A
Regarding the meeting of opposition unity in Bihar, the BJP is continuously targeting the leaders
The lockdown is in force till May 10 in Delhi to control the coronavirus infection. During this t
Makers including fans have high hopes for South Superstar Prabhas' upcoming film 'Salaar Part One
RR vs GT Playing 11 IPL 2023. The finalist teams of IPL 2022 Gujarat Titans and Rajasthan Royals